Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Graft Rejection, Date of authorisation: 23/04/2007, Revision: 26, Status: Authorised
SPOR and xEVMPD Stakeholder Engagement Webinars : Substance, product, organisation and referential (SPOR) application programming interface (API) - SPOR API, Online, from 12/10/2023 to 12/10/2023
SPOR and xEVMPD Stakeholder Engagement Webinars : Organisation Management Service (OMS), Online, from 04/10/2023 to 04/10/2023
SPOR and xEVMPD Stakeholder Engagement Webinars : Product Management Service (XEVMPD), Online, from 10/10/2023 to 10/10/2023
SPOR and xEVMPD Stakeholder Engagement Webinars : SPOR Data Governance, Online, from 02/10/2023 to 02/10/2023
CTIS newsflash – 27 October 2023
CTIS newsflash – 13 October 2023
EMA business hours over All Saints' Day and All Souls' Day, 1 and 2 November
Human medicines European public assessment report (EPAR): Lemtrada, alemtuzumab, Multiple Sclerosis, Date of authorisation: 12/09/2013, Revision: 22, Status: Authorised
SPOR and xEVMPD Stakeholder Engagement Webinars : EMA Account Management , Online, from 11/10/2023 to 11/10/2023